Vision Executives International Eye Care Recruitment
  • Home
  • About
  • Recruitment Services
  • Candidate Services
  • Vacancies
  • Eye Care News
  • Contact

Eye Care News

TRAINING OUR VISUAL SYSTEMS

16/3/2022

0 Comments

 
    NovaSight have recently announced their successful results of pivotal amblyopia treatment trial - CureSight. #Amblyopia, also known as lazy eye, is the most common eye issue amongst children, effecting as many as 3 in 100. 

    Currently, one of the most effective ways or treating amblyopia is by placing an eyepatch over the unaffected eye and forcing the "lazy eye" to work harder. Using a patch to treat a lazy eye can be time-consuming and can often be an unpleasant experience for the child until they get used to it. This is understandable – from their point of view, you're making their vision worse by taking their good eye away from them.

    NovaSight's study randomised participants between the ages of 4 and 9 and compared the improvement in visual outcomes achieved by CureSight digital treatment instead of using an eye patch. Their treatment is believed to be the first study to show that a digital device is not inferior to an eyepatch in treating amblyopia in children. "The success of the CureSight study is a critical step toward bringing this treatment for lazy eye to children around the world and to potentially modernizing the standard of care." Ran Yam, NovaSight CEO.

    RevitalVision is another company in this exciting space. Their breakthrough technology for treating adult amblyopia is the only #FDA approved therapy for patients aged 9+, with claims of improving vision. It provides significant vision improvement, the average being 2.5 lines on the visual acuity chart. This technology focuses on brain plasticity – the ability of the nervous system to adapt to changes in conditions for acquiring new skills. The neural training program is clinically proven and has had controlled randomised published studies. They are training the brain to be more efficient in processing visual information; using specialised algorithms to judge a patient’s performance and customise things to patients’ specific needs, according to their CEO Yair Yahav.

    As a result of these new technologies I wanted to ask my #eyecare & #ophthalmology network: Would you try visual training technology before resorting to traditional treatment methods?
    Refs - https://www.revitalvision.com/ https://eyewire.news/news/novasight-announces-successful-results-of-pivotal-amblyopia-treatment-trial?c4src=article:infinite-scroll
Submit
0 Comments



Leave a Reply.

    Author

    James Pickering is our Managing Director and an eye care recruitment expert who has developed an extensive client base and candidate network. He regularly writes articles about industry developments and has received numerous recommendations from industry leaders. You can also connect with James on LinkedIn to stay up to date on the latest eye care news.

    Archives

    December 2022
    October 2022
    September 2022
    August 2022
    June 2022
    May 2022
    April 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021

    Categories

    All
    Eye Care News

    RSS Feed

Picture

Location

Contact Us

Vision Executives Ltd
16 Market Place
Dewsbury
WF13 1AE
​United Kingdom

+44 (0) 1134900340
info@visionexecutives.com

Site Map

​Home
​
About
​Recruitment Services
​Candidate Services
Vacancies
Eye Care News
Contact
Vision Executives Ltd is a company registered in England & Wales. Company Number 13319387.
​Copyright © 2021 Vision Executives Ltd.
Click here to see our privacy policy.
  • Home
  • About
  • Recruitment Services
  • Candidate Services
  • Vacancies
  • Eye Care News
  • Contact